fda glp-1 warning 2025 november Novel Small Molecule Drug Approvals Pharmacovigilance analysis of neurological adverse

As the popularity of GLP-1 drugs continues to skyrocket, there has also been a huge rise in overdoses

A recent study found that GLP-1 medications like Ozempic and Wegovy may help improve breast cancer survival rates among women with obesity and type 2 diabetes.

The prevalence of type 2 diabetes (T2D) is increasing worldwide

The glucagon-like peptide-1 receptor (GLP-1R) is a class B G protein-coupled receptor and mainstay therapeutic target for the treatment of type 2 diabetes and obesity

Discover the facts about Wegovy's effects and how to manage your weight loss journey effectively.

For research use onlynot for human use